NLX-101 (F15599) is under development for the treatment of Rett syndrome and depression. The drug candidate is administered by oral route. The drug candidate is a new chemical entity (NCE). The drug ...

Mavoglurant is under development for the treatment of cocaine use disorder, alcohol use disorder and for language learning in young children with fragile X syndrome (FXS). The drug candidate is ...

Discover the truth in our NeuroQuiet reviews – does this hearing support supplement really deliver on its promises, or is it ...

NeuroQuiet is an advanced auditory support supplement that takes hearing experience to the next level. It strategically ...

Discover the truth about improved hearing with NeuroQuiet reviews—real experiences, benefits, and results revealed in this ...

Big Tech companies like Google and OpenAI are racing to release consumer products that can showcase uses for the snazzy new technology, even as naysayers warn that the lack of guardrails around ...

Premier Andrew Furey says under the new Churchill Falls agreement, N.L. will receive $1 billion a ... Furey said he has his eye on several ways to use the initial annual payments of $1 billion ...